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Introduction
Experiments have demonstrated the ability of action
potentials to actively backpropagate in striatal medium
spiny (MS) neurons, affecting the calcium levels in the
dendrites [1-3]. Increased calcium levels trigger changes in
plasticity [4,5], which is important for learning and other
functions [6]. Studies in the hippocampus have shown
that GABAergic input can modulate the backpropagation
of action potentials from the soma to the distal dendrites
[7]. The MS neurons receive both proximal feedforward
GABAergic inhibition from fast spiking interneurons (FS),
and distal feedback inhibition from other neighbouring
MS neurons. In the present study the effect of these
GABAergic inputs on the dendritic calcium dynamics is
investigated.
Model
A previously published MS model [8] was reimplemented
in GENESIS. The dendritic axial resistance and sodium
conductances have been modified to better fit experimen-
tal results [1-3]. For example, in the modified model,
backpropagation of dendritic action potentials requires
sodium channel activation, and fails if those channels are
blocked [1]. The MS neuron was activated by simulated
AMPA/NMDA and GABAergic synaptic inputs [8], or by
somatic current injections.
Computational investigation
In this study we compare the effect of FS and MS synaptic
inhibition on the backpropagation of action potentials in
the MS model. Preliminary results suggest that GABAerigic
inputs in distal dendrites can decrease the backpropagat-
ing action potential, and thus can reduce dendritic cal-
cium levels, even though the cell is still spiking in the
soma. These findings might suggest that feedback inhibi-
tion can control how prone the neighbouring MS neurons
will be to plastic changes.
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